top of page
Vision Group Propheta Pharmaceutical Company

Humanity has relied on nature for sustenance and medicinal remedies to maintain life and cure diseases. Propheta develops new medicines using natural and low-side-effect ingredients. We focus on antibody development through research on cyclically occurring viruses. 

 

   Propheta ensures the highest standards of safety and infrastructure with WHO-GMP and EDQM approvals, offering the best opportunities to uphold a healthy lifestyle for humanity.

Vision Group Propheta Pharmaceutical Company
21st Century Efforts for Humanity

Even in the present day, pharmaceutical and biotechnology companies around the world are dedicating themselves to the development of new medications that will safeguard and maintain human health.

 

When we examine the types of medications currently under development, it is evident that there is a significant focus on antibody development through cancer and virus research. Whenever the topic of medications is discussed, a common reminder is that even highly effective and beneficial drugs for treating diseases can become lethal poisons if used incorrectly.

 

Just like most things in the world, the true usefulness of medications can be maximized when used appropriately and in the right manner.

Vision Group Propheta Pharmaceutical Company
Natural-Derived New Drug Status

Global Development Trends: The global natural-derived market, including pharmaceuticals and health functional foods, is estimated to be worth around 1,000 trillion won (Korean currency) with an annual growth rate of 8~10%. Both domestically and internationally, countries are showing initiatives to gain leadership in the natural-derived market. In the pharmaceutical sector, the market size and share of natural-derived products are still relatively small.

Vision Group Propheta Pharmaceutical Company
Natural-Derived New Drug Future

Looking back at the history of pharmaceutical development, it began with natural-derived compounds and evolved into small-molecule pharmaceuticals using organic synthesis techniques, followed by the emergence of high-molecular-weight pharmaceuticals employing biotechnology (biopharmaceuticals, antibody drugs, etc.).

 

In recent times, active research is being conducted in gene therapy and regenerative medicine as well. In this historical context, there is a global movement valuing the diversity of chemical and biological entities found in natural-derived compounds as potential sources for new drug seeds.

 

Beyond traditional natural-derived new drug development, innovative research in related fields, utilizing technological breakthroughs, and exploring the potential of natural compounds from a chemical and life sciences perspective are highly anticipated.

bottom of page